305 related articles for article (PubMed ID: 23838905)
1. Margin width should not still enforce a systematic surgical re-excision in the conservative treatment of early breast infiltrative ductal carcinoma.
Jaffré I; Campion L; Dejode M; Bordes V; Sagan C; Loussouarn D; Dravet F; Andrieux N; Classe JM
Ann Surg Oncol; 2013 Nov; 20(12):3831-8. PubMed ID: 23838905
[TBL] [Abstract][Full Text] [Related]
2. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
3. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
4. Margin width is not predictive of residual disease on re-excision in breast conserving therapy.
Hadzikadic Gusic L; McGuire KP; Ozmen T; Soran A; Thomas CR; McAuliffe PF; Diego EJ; Bonaventura M; Johnson RR; Ahrendt GM
J Surg Oncol; 2014 Apr; 109(5):426-30. PubMed ID: 24338603
[TBL] [Abstract][Full Text] [Related]
5. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
6. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.
Atalay C; Irkkan C
Breast J; 2012; 18(4):339-44. PubMed ID: 22616572
[TBL] [Abstract][Full Text] [Related]
8. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study.
Bodilsen A; Bjerre K; Offersen BV; Vahl P; Ejlertsen B; Overgaard J; Christiansen P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S476-85. PubMed ID: 26178760
[TBL] [Abstract][Full Text] [Related]
10. Close/positive margins after breast-conserving therapy: additional resection or no resection?
Wood WC
Breast; 2013 Aug; 22 Suppl 2():S115-7. PubMed ID: 24074771
[TBL] [Abstract][Full Text] [Related]
11. Negative margin status improves local control in conservatively managed breast cancer patients.
Obedian E; Haffty BG
Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
[TBL] [Abstract][Full Text] [Related]
12. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
[TBL] [Abstract][Full Text] [Related]
13. Margin re-excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model.
Abe SE; Hill JS; Han Y; Walsh K; Symanowski JT; Hadzikadic-Gusic L; Flippo-Morton T; Sarantou T; Forster M; White RL
J Surg Oncol; 2015 Sep; 112(4):443-8. PubMed ID: 26374088
[TBL] [Abstract][Full Text] [Related]
14. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
[TBL] [Abstract][Full Text] [Related]
15. A comparison of intra-operative margin management techniques in breast-conserving surgery: a standardised approach reduces the likelihood of residual disease without increasing operative time.
Bolger JC; Solon JG; Khan SA; Hill AD; Power CP
Breast Cancer; 2015 May; 22(3):262-8. PubMed ID: 23649303
[TBL] [Abstract][Full Text] [Related]
16. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
Biglia N; Ponzone R; Bounous VE; Mariani LL; Maggiorotto F; Benevelli C; Liberale V; Ottino MC; Sismondi P
Breast; 2014 Dec; 23(6):870-5. PubMed ID: 25305040
[TBL] [Abstract][Full Text] [Related]
17. Extent of margin involvement, lymphovascular invasion, and extensive intraductal component predict for residual disease after wide local excision for breast cancer.
Alrahbi S; Chan PM; Ho BC; Seah MD; Chen JJ; Tan EY
Clin Breast Cancer; 2015 Jun; 15(3):219-26. PubMed ID: 25576998
[TBL] [Abstract][Full Text] [Related]
18. Review of re-excision for narrow or positive margins of invasive and intraductal carcinoma.
Gupta A; Subhas G; Dubay L; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Gorieil Y; Mittal VK
Am Surg; 2010 Jul; 76(7):731-4. PubMed ID: 20698380
[TBL] [Abstract][Full Text] [Related]
19. Discordance between pathologic and radiologic tumor size on breast MRI may contribute to increased re-excision rates.
Vanderwalde LH; Dang CM; Bresee C; Phillips EH
Am Surg; 2011 Oct; 77(10):1361-3. PubMed ID: 22127089
[TBL] [Abstract][Full Text] [Related]
20. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery.
Ward ST; Jones BG; Jewkes AJ
Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
